human breast cancer s c xenograft Search Results


human breast cancer s c xenograft  (ATCC)
97
ATCC human breast cancer s c xenograft
Tumor growth inhibition of <t>human</t> s.c. <t>xenografts</t> of <t>breast</t> <t>cancer</t> T47D after oral administration of anthrafuran (70 mg/kg for 5 days).
Human Breast Cancer S C Xenograft, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+breast+cancer+s+c+xenograft/T-47D%3B+Breast+Cancer%3B+Human/pmc07281648-80-5-22
Average 97 stars, based on 1 article reviews
human breast cancer s c xenograft - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

Image Search Results


Tumor growth inhibition of human s.c. xenografts of breast cancer T47D after oral administration of anthrafuran (70 mg/kg for 5 days).

Journal: Pharmaceuticals

Article Title: Experimental Evaluation of Anticancer Efficiency and Acute Toxicity of Anthrafuran for Oral Administration †

doi: 10.3390/ph13050081

Figure Lengend Snippet: Tumor growth inhibition of human s.c. xenografts of breast cancer T47D after oral administration of anthrafuran (70 mg/kg for 5 days).

Article Snippet: For the final study, a human breast cancer s.c. xenograft of T47D with an autocrine regulation of cell proliferation by estrogen receptor-alpha (ATCC ® HTB-133) was used.

Techniques: Inhibition